155 related articles for article (PubMed ID: 22916597)
1. [Management of dyslipidemia in HIV-infected patients].
Moog AM; Becker W
MMW Fortschr Med; 2012 May; 154 Suppl 1():34-6. PubMed ID: 22916597
[No Abstract] [Full Text] [Related]
2. Ischemic Heart Disease in HIV: An In-depth Look at Cardiovascular Risk.
Raposeiras-Roubín S; Triant V
Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1204-1213. PubMed ID: 27840147
[TBL] [Abstract][Full Text] [Related]
3. [HAART influences the lipids].
Behrens G
MMW Fortschr Med; 2009 Apr; 151(18):36-8. PubMed ID: 19769073
[No Abstract] [Full Text] [Related]
4. ["No infarct without elevated LDL cholesterol"!].
Greten H
MMW Fortschr Med; 2008 Nov; 150(48):119. PubMed ID: 19125517
[No Abstract] [Full Text] [Related]
5. [On the current debate on lowering LDL cholesterol with ezetimibe].
Breuer HW
Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008
[No Abstract] [Full Text] [Related]
6. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
Bruckert E; Giral P; Tellier P
Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
[No Abstract] [Full Text] [Related]
7. The statin era: in search of the ideal lipid regulating agent.
Shepherd J
Heart; 2001 Mar; 85(3):259-64. PubMed ID: 11179260
[No Abstract] [Full Text] [Related]
8. When a statin fails.
Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
[No Abstract] [Full Text] [Related]
9. Treatment of dyslipidemia in HIV.
Sekhar RV
Curr Atheroscler Rep; 2015 Apr; 17(4):493. PubMed ID: 25702057
[TBL] [Abstract][Full Text] [Related]
10. [Hyperlipidemia: decreasing lipid values and effects of statins].
Mathes P
Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
[No Abstract] [Full Text] [Related]
11. IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"?
Masana L; Pedro-Botet J; Civeira F
Atherosclerosis; 2015 May; 240(1):161-2. PubMed ID: 25795557
[No Abstract] [Full Text] [Related]
12. [Are high levels of HDL always associated with a reduced risk of myocardial infarction? - lipid therapy should still focus on lowering LDL cholesterol levels].
Laufs U
Dtsch Med Wochenschr; 2012 Oct; 137(43):2200. PubMed ID: 23076665
[No Abstract] [Full Text] [Related]
13. LDL-Cholesterol is the King.
Goumas GS
Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
[No Abstract] [Full Text] [Related]
14. [Statins-a panacea?].
Klose G
Z Kardiol; 2004; 93 Suppl 1():I19-22. PubMed ID: 15022003
[TBL] [Abstract][Full Text] [Related]
15. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts].
MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509
[No Abstract] [Full Text] [Related]
16. [Dyslipidemia management in patients with impaired glucose tolerance].
Asano M; Yamada N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():538-42. PubMed ID: 15779437
[No Abstract] [Full Text] [Related]
17. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
[TBL] [Abstract][Full Text] [Related]
18. Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine.
Castro JG; Gutierrez L
Am J Med; 2002 Apr; 112(6):505. PubMed ID: 11959068
[No Abstract] [Full Text] [Related]
19. Complications & side effects. Can statins be used as anti-HIV drugs?
TreatmentUpdate; 2004; 16(7):9. PubMed ID: 17219689
[No Abstract] [Full Text] [Related]
20. [Hemorheological aspects of hyperlipidemia].
Elishkewitch K; Shapira I; Berliner S
Harefuah; 2001 May; 140(5):435-6. PubMed ID: 11419070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
